The Numbers That Matter: In the landmark SURMOUNT-5 trial published in the New England Journal of Medicine in May 2025, participants taking tirzepatide lost an average of 20.2% of their body weight over 72 weeks, compared to 13.7% with semaglutide
For busy professionals in North Georgia seeking a wellness boost, understanding the right dosage is key
FDA Warnings and Post-Market Safety Studies The most serious side effects associated with Januvia and Janumet are acute pancreatitis and severe joint pain
Research suggests it can support significant weight loss and may improve blood pressure in some adults with obesity or excess weight
Rather, it suggests that among people taking GLP-1 medications, two well-established risk factors for violence impulsivity and alcohol use appear to have a weaker relationship with violent behavior, she told Healthline
The cost of Semaglutide GLP-1 varies depending on your insurance plan